Skip to main content
Top
Published in: Intensive Care Medicine 8/2008

Open Access 01-08-2008 | Brief Report

Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery

Authors: Emile F. Schippers, Jimmy F. P. Berbée, Inge M. van Disseldorp, Michael I. M. Versteegh, Louis M. Havekes, Patrick C. N. Rensen, Jaap T. van Dissel

Published in: Intensive Care Medicine | Issue 8/2008

Login to get access

Abstract

Objective

Experimental models show that apolipoprotein CI (apoCI) binds and enhances the inflammatory response to endotoxin. We studied in patients undergoing cardiopulmonary bypass surgery (CPB) and experiencing endotoxemia during reperfusion whether plasma apoCI levels correlate with the inflammatory response and perioperative cytokine release.

Design

Prospective, observational, clinical cohort study.

Setting

Operating room (OR) and intensive care unit (ICU) of a university hospital.

Patients

One hundred fifty-nine consecutive patients > 18 years of age (66% males (n = 105), median age 65 and 67 years for males and females, respectively) undergoing elective cardiothoracic surgery with cardiopulmonary bypass.

Interventions

None.

Measurements

Baseline apoCI, apoCIII, total cholesterol and triglyceride levels, and perioperative endotoxin and TNF-α levels were determined.

Results

High preoperative plasma apoCI, but not apoCIII, levels were associated (p < 0.05) with increased perioperative levels of TNF-α in patients experiencing endotoxemia. This association was not observed in patients without endotoxemia.

Conclusion

High plasma apoCI is positively related to proinflammatory response in patients experiencing endotoxemia and confirms the observations in animal models.
Literature
1.
go back to reference Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 65:3749–3752 Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 65:3749–3752
2.
go back to reference Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, Golenbock DT, Freeman MW (2000) Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 165:4272–4280PubMed Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, Golenbock DT, Freeman MW (2000) Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 165:4272–4280PubMed
3.
go back to reference Berbee JF, Havekes LM, Rensen PC (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11:97–103PubMed Berbee JF, Havekes LM, Rensen PC (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11:97–103PubMed
4.
go back to reference Feingold KR, Grunfeld C (1997) Lipoproteins: Are they important components of host defense? Hepatology 26:1685–1686PubMedCrossRef Feingold KR, Grunfeld C (1997) Lipoproteins: Are they important components of host defense? Hepatology 26:1685–1686PubMedCrossRef
5.
go back to reference Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ (1997) Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 99:2438–2445PubMedCrossRef Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ (1997) Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 99:2438–2445PubMedCrossRef
6.
go back to reference van den Elzen EP, Garg S, Leon L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA et al. (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437:906–910PubMedCrossRef van den Elzen EP, Garg S, Leon L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA et al. (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437:906–910PubMedCrossRef
7.
go back to reference de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, van Dijk KW, van der Meer JW, Stalenhoef AF (1999) Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40:680–685PubMed de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, van Dijk KW, van der Meer JW, Stalenhoef AF (1999) Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40:680–685PubMed
8.
go back to reference Ma J, Liao XL, Lou B, Wu MP (2004) Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sin (Shanghai) 36:419–424CrossRef Ma J, Liao XL, Lou B, Wu MP (2004) Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sin (Shanghai) 36:419–424CrossRef
9.
go back to reference van Oosten M, Rensen PC, van Amersfoort ES, van Eck M, van Dam AM, Breve JJ, Vogel T, Panet A, van Berkel TJ, Kuiper J (2001) Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat Gram-negative sepsis. J Biol Chem 276:8820–8824PubMedCrossRef van Oosten M, Rensen PC, van Amersfoort ES, van Eck M, van Dam AM, Breve JJ, Vogel T, Panet A, van Berkel TJ, Kuiper J (2001) Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat Gram-negative sepsis. J Biol Chem 276:8820–8824PubMedCrossRef
10.
go back to reference Berbee JF, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J 20:2162–2164PubMedCrossRef Berbee JF, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J 20:2162–2164PubMedCrossRef
11.
go back to reference Berbee JF, Schippers EF, van der Hoogt CC, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the inflammatory response to lipopolysaccharide in mice and humans. Atherosclerosis S7:227 Berbee JF, Schippers EF, van der Hoogt CC, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the inflammatory response to lipopolysaccharide in mice and humans. Atherosclerosis S7:227
12.
go back to reference Westerterp M, Berbee JF, Pires NM, van Mierlo GJ, Kleemann R, Romijn JA, Havekes LM, Rensen PC (2007) Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116:2173–2181PubMedCrossRef Westerterp M, Berbee JF, Pires NM, van Mierlo GJ, Kleemann R, Romijn JA, Havekes LM, Rensen PC (2007) Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116:2173–2181PubMedCrossRef
13.
go back to reference Berbee JF, Mooijaart SP, de Craen AJ, Havekes LM, van Heemst D, Rensen PC, Westendorp RG (2008) Plasma apolipoprotein CI protects against mortality from infection in old age. J Gerontol A Biol Sci Med Sci 63:122–126 Berbee JF, Mooijaart SP, de Craen AJ, Havekes LM, van Heemst D, Rensen PC, Westendorp RG (2008) Plasma apolipoprotein CI protects against mortality from infection in old age. J Gerontol A Biol Sci Med Sci 63:122–126
14.
go back to reference Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T, Mountford PJ, Bion JF (1996) Intestinal permeability, gastric intramucosal PH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. J Am Med Assoc 275:1007–1012CrossRef Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T, Mountford PJ, Bion JF (1996) Intestinal permeability, gastric intramucosal PH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. J Am Med Assoc 275:1007–1012CrossRef
15.
go back to reference Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT (2002) No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 30:38–43PubMedCrossRef Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT (2002) No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 30:38–43PubMedCrossRef
16.
go back to reference Oudemans-van Straaten HM, Jansen PG, Hoek FJ, van Deventer SJ, Sturk A, Stoutenbeek CP, Tytgat GN, Wildevuur CR, Eysman L (1996) Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 10:187–194PubMedCrossRef Oudemans-van Straaten HM, Jansen PG, Hoek FJ, van Deventer SJ, Sturk A, Stoutenbeek CP, Tytgat GN, Wildevuur CR, Eysman L (1996) Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 10:187–194PubMedCrossRef
17.
go back to reference Rossi M, Sganga G, Mazzone M, Valenza V, Guarneri S, Portale G, Carbone L, Gatta L, Pioli C, Sanguinetti M et al. (2004) Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg 77:612–618PubMedCrossRef Rossi M, Sganga G, Mazzone M, Valenza V, Guarneri S, Portale G, Carbone L, Gatta L, Pioli C, Sanguinetti M et al. (2004) Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg 77:612–618PubMedCrossRef
18.
go back to reference Schippers EF, van 't Veer C, van Voorden S, Martina CA, le Cessie S, van Dissel JT (2004) TNF-alpha promoter, Nod2 and Toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 26:16–24PubMedCrossRef Schippers EF, van 't Veer C, van Voorden S, Martina CA, le Cessie S, van Dissel JT (2004) TNF-alpha promoter, Nod2 and Toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 26:16–24PubMedCrossRef
19.
go back to reference Schippers EF, van 't Veer C, van Voorden JB, Huizinga T, le Cessie S, van Dissel JT (2005) IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 29:215–228PubMedCrossRef Schippers EF, van 't Veer C, van Voorden JB, Huizinga T, le Cessie S, van Dissel JT (2005) IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 29:215–228PubMedCrossRef
20.
go back to reference van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W (1988) Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 340:605–609CrossRef van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W (1988) Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 340:605–609CrossRef
21.
go back to reference van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PH, Westendorp R G, van Dissel JT (2000) Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 31:1343–1348PubMedCrossRef van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PH, Westendorp R G, van Dissel JT (2000) Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 31:1343–1348PubMedCrossRef
22.
go back to reference Schaap FG, Nierman MC, Berbee JF, Hattori H, Talmud PJ, Vaessen SF, Rensen PC, Chamuleau RA, Kuivenhoven JA, Groen AK (2006) Evidence for a complex relationship between ApoA-V and ApoC-III in patients with severe hypertriglyceridemia. J Lipid Res 47:2333–2339PubMedCrossRef Schaap FG, Nierman MC, Berbee JF, Hattori H, Talmud PJ, Vaessen SF, Rensen PC, Chamuleau RA, Kuivenhoven JA, Groen AK (2006) Evidence for a complex relationship between ApoA-V and ApoC-III in patients with severe hypertriglyceridemia. J Lipid Res 47:2333–2339PubMedCrossRef
Metadata
Title
Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery
Authors
Emile F. Schippers
Jimmy F. P. Berbée
Inge M. van Disseldorp
Michael I. M. Versteegh
Louis M. Havekes
Patrick C. N. Rensen
Jaap T. van Dissel
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2008
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1077-9

Other articles of this Issue 8/2008

Intensive Care Medicine 8/2008 Go to the issue